• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2000年至2006年墨西哥肝癌的死亡率趋势。

Mortality trends for liver cancer in Mexico from 2000 to 2006.

作者信息

Méndez-Sánchez Nahum, Villa Antonio R, Vázquez-Elizondo Genaro, Ponciano-Rodríguez Guadalupe, Uribe Misael

机构信息

Liver Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico.

出版信息

Ann Hepatol. 2008 Jul-Sep;7(3):226-9.

PMID:18753989
Abstract

UNLABELLED

Hepatocellular carcinoma (HCC) is the most common primary liver cancer, with an estimated incidence of half a million new cases per year around the world. Furthermore, HCC is the third greatest cause of cancer-related death in the world, and most of these deaths are registered in developing countries. Recently it has been suggested that Hispanics in the United States have high rates of HCC, but no information regarding this is available in Mexico. The aim of this study was to investigate recent trends (2000-2006) in HCC mortality rates in Mexico.

METHODS

Data on national mortality (death certificates) reported for the years 2000-2006 by the Health Ministry of Mexico were analyzed (www.salud.gob.mx). HCC as a cause of death was analyzed. Mortality rates were calculated for all population ages. Causes of death related to HCC were selected in accordance with the International Classification of Diseases, 10th Revision, Liver Cancer (C22.0, C22.7, C22.9).

RESULTS

We found that age-adjusted mortality rates were remarkably higher in men than in women in the period 2000-2006. In addition, we found an increase in the general mortality rates of HCC from 4.1 per 100,000 in 2000 to 4.7 per 100,000 in 2006.

CONCLUSIONS

The results of this study suggest an increase in the mortality rate for HCC in the period 2000-2006. HCC will become a significant cause of morbidity and mortality in the near future.

摘要

未标注

肝细胞癌(HCC)是最常见的原发性肝癌,全球每年估计有五十万新发病例。此外,HCC是全球第三大致癌相关死亡原因,且大多数死亡病例发生在发展中国家。最近有研究表明,美国的西班牙裔人群HCC发病率较高,但墨西哥尚无相关信息。本研究旨在调查墨西哥肝细胞癌死亡率的近期趋势(2000 - 2006年)。

方法

分析了墨西哥卫生部报告的2000 - 2006年全国死亡率数据(www.salud.gob.mx)。对作为死亡原因的HCC进行了分析。计算了所有年龄段人群的死亡率。与HCC相关的死亡原因按照国际疾病分类第十版肝癌(C22.0、C22.7、C22.9)进行选择。

结果

我们发现,2000 - 2006年期间,年龄调整后的死亡率男性显著高于女性。此外,我们发现HCC的总体死亡率从2000年的每10万人4.1例增加到了2006年的每10万人4.7例。

结论

本研究结果表明,2000 - 2006年期间HCC死亡率有所上升。在不久的将来,HCC将成为发病和死亡的重要原因。

相似文献

1
Mortality trends for liver cancer in Mexico from 2000 to 2006.2000年至2006年墨西哥肝癌的死亡率趋势。
Ann Hepatol. 2008 Jul-Sep;7(3):226-9.
2
Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.1975年至2005年美国肝细胞癌的发病率、死亡率及生存趋势
J Clin Oncol. 2009 Mar 20;27(9):1485-91. doi: 10.1200/JCO.2008.20.7753. Epub 2009 Feb 17.
3
Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.美国肝细胞癌发病率和肝癌死亡率的变化。
Am J Gastroenterol. 2014 Apr;109(4):542-53. doi: 10.1038/ajg.2014.11. Epub 2014 Feb 11.
4
Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004.1980年至2004年欧洲肝细胞癌死亡率趋势
Hepatology. 2008 Jul;48(1):137-45. doi: 10.1002/hep.22312.
5
Disparity in liver cancer incidence and chronic liver disease mortality by nativity in Hispanics: The Multiethnic Cohort.西班牙裔人群中肝癌发病率和慢性肝病死亡率按出生地划分的差异:多族裔队列研究
Cancer. 2016 May 1;122(9):1444-52. doi: 10.1002/cncr.29922. Epub 2016 Feb 24.
6
Texas Has the Highest Hepatocellular Carcinoma Incidence Rates in the USA.得克萨斯州是美国肝癌发病率最高的州。
Dig Dis Sci. 2021 Mar;66(3):912-916. doi: 10.1007/s10620-020-06231-4. Epub 2020 Apr 17.
7
Mortality from hepatocellular and biliary cancers: changing epidemiological trends.肝细胞癌和胆管癌的死亡率:不断变化的流行病学趋势。
Am J Gastroenterol. 2002 Jan;97(1):167-71. doi: 10.1111/j.1572-0241.2002.05432.x.
8
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
9
Burden of hepatocellular carcinoma in Iran; Bayesian projection and trend analysis.伊朗肝细胞癌负担;贝叶斯预测与趋势分析。
Asian Pac J Cancer Prev. 2010;11(4):859-62.
10
Global trends and predictions in hepatocellular carcinoma mortality.全球肝癌死亡率的趋势和预测。
J Hepatol. 2017 Aug;67(2):302-309. doi: 10.1016/j.jhep.2017.03.011. Epub 2017 Mar 21.

引用本文的文献

1
Global trends in hepatitis C-related hepatocellular carcinoma mortality: A public database analysis (1999-2019).丙型肝炎相关肝细胞癌死亡率的全球趋势:一项公共数据库分析(1999 - 2019年)
World J Virol. 2024 Mar 25;13(1):89469. doi: 10.5501/wjv.v13.i1.89469.
2
The trends in death of primary liver cancer caused by specific etiologies worldwide: results from the Global Burden of Disease Study 2019 and implications for liver cancer management.全球特定病因原发性肝癌死亡趋势:2019 年全球疾病负担研究结果及其对肝癌管理的影响。
BMC Cancer. 2023 Jun 28;23(1):598. doi: 10.1186/s12885-023-11038-3.
3
Liver cancer in Hidalgo State, Mexico: analysis of the status, risk factors and regional public health policy requirements: a cross-sectional correlational study.
墨西哥伊达尔戈州的肝癌:现状、风险因素和区域公共卫生政策要求的分析:一项横断面相关性研究。
Sao Paulo Med J. 2022 Jul-Aug;140(4):574-582. doi: 10.1590/1516-3180.2021.0601.R1.121121.
4
Hepatocellular Carcinoma in Mexico.墨西哥的肝细胞癌
Clin Liver Dis (Hoboken). 2022 Mar 10;19(2):73-77. doi: 10.1002/cld.1196. eCollection 2022 Feb.
5
Migration from Mexico to the United States: A high-speed cancer transition.从墨西哥移民到美国:癌症的高速转变。
Int J Cancer. 2018 Feb 1;142(3):477-488. doi: 10.1002/ijc.31068. Epub 2017 Oct 12.
6
Incidence of hepatocellular carcinoma in outpatients with cirrhosis in Brazil: A 10-year retrospective cohort study.巴西肝硬化门诊患者肝细胞癌的发病率:一项10年回顾性队列研究。
World J Gastroenterol. 2016 Dec 14;22(46):10219-10225. doi: 10.3748/wjg.v22.i46.10219.
7
Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma.使用靶向治疗延长肝细胞癌治疗中的生存期。
Gastroenterol Hepatol (N Y). 2013 Apr;9(4 Suppl 2):1-24.
8
Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia.哥伦比亚肝细胞癌中的乙型肝炎和丙型肝炎感染生物标志物及TP53突变
Hepat Res Treat. 2011;2011:582945. doi: 10.1155/2011/582945. Epub 2011 Oct 31.